GNQ Insilico, Inc. (GNQ), a precision medicine TechBio company, today announced a collaboration with IBM aimed to help healthcare and life sciences organizations accelerate the ad ...
Every major consultancy is selling an AI governance framework right now. The market is crowded: maturity models, policy ...
The FCA's 2024 arrears management review said something that should have made every mortgage servicer uncomfortable: firms ...
- Fueled by best-in-class technology and deep expertise in genome engineering and AI, PerturbAI is uniquely positioned to redefine therapeutic discovery, making it more scalable, translatable and cost ...
Key findings presented at the Keystone Symposia on Obesity Therapeutics SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, the AI therapeutics company built on causal biology, today reported ...
Boston-based biotech powers AI with function-anchored data that reveals biological cause--not just correlation--across drug discovery, clinical development, and diagnostics. BOSTON, April 16, 2026 ...
Do AI chatbots understand reality? Researchers used "AI neuroscience" to prove that language models develop internal world models that mirror human intuition.
Tech stock declines highlight unsustainable AI spending; EssentaTor proposes Mapping Mathematics for durable, efficient intelligence systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results